Quick Answer
ACTUATE THERAPEUTICS, INC. reported Shares Outstanding of 23.25 million shares for fiscal year 2025.
ACTUATE THERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 23.25M | +19.0% |
| 2024 | 19.53M | +1055.2% |
| 2023 | 1.69M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 23.24M | +19.0% | +13.5% |
| June 30, 2025 | 20.47M | +1110.7% | +4.8% |
| March 31, 2025 | 19.53M | — | +0.0% |
| December 31, 2024 | 19.53M | +1055.2% | +0.0% |
| September 30, 2024 | 19.53M | — | +1055.2% |
| June 30, 2024 | 1.69M | — | +0.0% |
| December 31, 2023 | 1.69M | — | — |
- ACTUATE THERAPEUTICS, INC. showed an increase of +19.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, ACTUATE THERAPEUTICS, INC.’s shares outstanding has grown by 1274.8% (from 1.69 million shares to 23.25 million shares).
- The most recent figure is from ACTUATE THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: